BMJ Neurol Open. 2020 Dec 14;2(2):e000101. doi: 10.1136/bmjno-2020-000101. eCollection 2020.
ABSTRACT
COVID-19 is a significant global health burden. The pulmonary morbidity and mortality of COVID-19 is well described, however, there is mounting evidence of neurological manifestations of SARS-CoV-2, which may be of prognostic significance. This paper summarises the available evidence in order to provide clinicians with a concise summary of the peripheral and central neurological manifestations of COVID-19, discusses specific issues regarding the management of chronic neurological disease in the context of the pandemic, and provides a summary of the thrombotic implications of the disease for the neurologist.
PMID:33681805 | PMC:PMC7871721 | DOI:10.1136/bmjno-2020-000101